Enliven Therapeutics, Inc. ELVN

Set alert

51.55 USD +2.12 (+4.29%)

At closeNov 9, 2026, 5:34 PM EST

51.98 +0.43 +0.83%

After hours · Nov 9, 5:34 PM ET

48.77 Day range 51.86

14.79 52-week range 62.32

Held by insiders 6.22%

Held by institutions 117.24%

Float held by institutions 125.02%

Institutions 306

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	13.62%	10,025,017	516.79M	Jun 29, 2026
Orbimed Advisors LLC.	9.21%	6,776,632	349.34M	Jun 29, 2026
Polar Capital Holdings PLC	8.74%	6,430,636	331.50M	Jun 29, 2026
Blackrock Inc.	5.92%	4,359,704	224.74M	Jun 29, 2026
Vestal Point Capital, LP	5.44%	4,000,000	206.20M	Jun 29, 2026
Commodore Capital Lp	4.45%	3,275,000	168.83M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.56%	1,883,372	97.09M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.05%	1,508,364	77.76M	Sep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio	1.74%	1,280,000	65.98M	Sep 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth Fund	1.70%	1,250,754	64.48M	Aug 30, 2026
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total	1.53%	1,123,263	57.90M	Sep 29, 2026
T. Rowe Price New Horizons Fund, Inc.	1.10%	807,329	41.62M	Jun 29, 2026

ELVN insiders
Insider	Relation	Latest transaction	Date	Shares held
COLLINS HELEN LOUISE	Officer	Sale	Oct 18, 2026	25,000
DERYNCK MIKA K	Director	Sale	Aug 3, 2026	0
GARLAND J SCOTT	Director	Sale	Sep 30, 2026	0
HEYMAN RICHARD A	Director	Sale	Feb 16, 2026	0
HOHL BENJAMIN	Chief Financial Officer	Sale	Oct 18, 2026	38,000
KINTZ SAMUEL	Chief Executive Officer	Sale	Nov 16, 2025	0

Held by funds